iCAD (ICAD) announced the appointment of Mark Koeniguer as chief commercial officer to lead the next phase of global growth for iCAD. As CCO at iCAD, Koeniguer will assume responsibilities for revenue growth across North America and around the globe, bringing with him extensive executive experience in the medical imaging field and software as a medical device space. In his new role, Mark will have oversight of the commercial sales teams, partnerships, operations and customer success. Most recently, he served as CEO of ScreenPoint Medical, where he transformed the company from a science-led organization into a global commercial enterprise, increasing annual recurring revenue by 400% and launching two FDA-cleared products.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICAD: